Amanote Research
Register
Sign In
Vitamin K Antagonist Embryofetopathy
doi 10.32388/xten1b
Full Text
Open PDF
Abstract
Available in
full text
Date
February 10, 2020
Authors
Unknown
Publisher
Qeios
Related search
P-Glycoprotein: A Clue to Vitamin K Antagonist Stabilization
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Pharmacological Profile of Non-Vitamin K Antagonist Oral Anticoagulants
African Journal of Pharmacy and Pharmacology
Pharmacokinetics and Pharmacodynamics of Tecarfarin, a Novel Vitamin K Antagonist Oral Anticoagulant
Thrombosis and Haemostasis
Hematology
Physician's Hand on the International Normalized Ratio Level of Vitamin K Antagonist
Journal of Arrhythmia
Cardiovascular Medicine
Cardiology
Safety of Switching From Vitamin K Antagonist to Non-Vitamin K Antagonist Oral Anticoagulant in Frail Elderly With Atrial Fibrillation: Rationale and Design of the FRAIL-AF Randomised Controlled Trial
BMJ Open
Medicine
Effective Management of Venous Thromboembolism in the Community: Non-Vitamin K Antagonist Oral Anticoagulants
International Journal of General Medicine
Medicine
Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Methimazole Embryofetopathy
Aminopterin/Methotrexate Embryofetopathy
